Hypoxia-Inducible Factors in Liver Metabolism

肝脏代谢中的缺氧诱导因素

• 批准号: 8446375
• 负责人: Volker Hans Haase
• 金额: $ 32.12万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-20 至 2015-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8446375
• 关键词: Acute; Adenoviruses; Adult; Albumins; Alcohol consumption; Alcoholic Liver Diseases; Applications Grants; BHLH Protein; Binding; Biological Process; Blood; Cell Line; Cell Nucleus; Complex; Data; Development; Diabetes Mellitus; EP300 gene; Erythropoiesis; Event; Exploratory/Developmental Grant; Family; Fatty Acids; Fatty Liver; Fatty acid glycerol esters; Funding; Gene Expression; Gene Targeting; Gene Transfer Techniques; Generations; Genes; Genetic; Genetic Transcription; Glycolysis; Goals; Grant; Hepatic; Hepatocyte; Homeostasis; Homologous Gene; Hydroxylation; Hypoxia; Hypoxia Inducible Factor; Hypoxia-Inducible Factor Pathway; In Vitro; Injury; Iron; Knock-out; Knockout Mice; Lead; Link; Liver; Liver diseases; Lung; Mammalian Cell; Mediating; Mediator of activation protein; Metabolic; Molecular; Mus; Mutant Strains Mice; Mutation; National Institute of Diabetes and Digestive and Kidney Diseases; Nucleic Acid Regulatory Sequences; Obesity; Oxygen; Pathogenesis; Patients; Physiological; Play; Primary Cell Cultures; Proline; Proteins; Regulation; Response Elements; Role; SLC2A1 gene; Signal Transduction; Technology; Testing; Tetanus Helper Peptide; Tetracyclines; Tissues; Transferrin; Transgenes; Transgenic Mice; Transgenic Organisms; Tumor Suppressor Proteins; Vascular Endothelial Growth Factors; adenovirus mediated delivery; adipocyte differentiation; angiogenesis; bHLH-PAS factor HLF; cell type; clinically relevant; deprivation; fatty acid metabolism; glucose uptake; hepatoma cell; human ARNT protein; hypoxia inducible factor 1; in vivo; iron metabolism; lipid metabolism; liver metabolism; member; non-alcoholic fatty liver; novel; oxidation; promoter; protein expression; public health relevance; recombinase; transcription factor; ubiquitin-protein ligase; uptake

DESCRIPTION (provided by applicant): Nonalcoholic fatty liver disease (NAFLD) occurs in patients without significant alcohol consumption and represents a clinico-histopathological entity with histological features that resemble alcohol-induced liver injury. We have used conditional gene targeting in hepatocytes to inactivate the pVHL-E3-ubiquitin ligase, which targets Hypoxia-Inducible-Factor (HIF) for degradation under normoxia. We have discovered that increased HIF activity alters fatty acid metabolism and results in the development of non-alcoholic fatty liver disease in mice. Hypoxia-Inducible Factor-1 and -2 (HIF-1 and HIF-2) are heterodimeric basic-loop-helix transcription factors and are key mediators of cellular adaptation to diminished oxygen supply. Our findings implicate HIF signaling, in particular signaling through HIF-2, in the development of fatty liver disease. In this grant application we propose in vivo and in vitro studies that make use of conditional gene targeting technology and transgenesis to investigate the role of HIF signaling in the regulation of fatty acid uptake, synthesis, beta-oxidation and secretion. Additional in vitro studies are proposed that specifically focus on selected HIF target genes to study their role in lipid metabolism under hypoxia. In Aim 1 we carry out functional studies in VHL mutant mice, in Aim 2 we investigate the role of HIF activation early in the development of steatosis following acute inactivation of pVHL in the adult, and Aims 3 and 4 investigate the role of HIF-2 in a wild type genetic background with a focus on HIF-2 target genes relevant for the development of steatosis. The proposed studies are not only important for our understanding of basic HIF functions in lipid metabolism, but more importantly have direct clinical relevance. We provide a direct molecular link between hypoxic injury and fatty liver development and establish a novel role for the HIF pathway in the pathogenesis of NAFLD.

描述（由申请方提供）：非酒精性脂肪性肝病（NAFLD）发生在无显著饮酒的患者中，代表一种临床组织病理学实体，其组织学特征类似于酒精诱导的肝损伤。我们已经在肝细胞中使用了条件性基因靶向来抑制pVHL-E3-泛素连接酶，其靶向低氧诱导因子（HIF）以在常氧下降解。我们已经发现，增加HIF活性改变脂肪酸代谢，并导致小鼠非酒精性脂肪肝疾病的发展。缺氧诱导因子-1和-2（HIF-1和HIF-2）是异源二聚体碱性环螺旋转录因子，并且是细胞适应减少的氧供应的关键介质。我们的研究结果暗示HIF信号，特别是通过HIF-2的信号，在脂肪肝疾病的发展。在这项资助申请中，我们提出了体内和体外研究，利用条件基因靶向技术和转基因研究HIF信号在调节脂肪酸摄取，合成，β-氧化和分泌中的作用。提出了额外的体外研究，特别关注选定的HIF靶基因，以研究它们在缺氧条件下的脂质代谢中的作用。在目的1中，我们在VHL突变小鼠中进行功能研究，在目的2中，我们研究了HIF激活在成人pVHL急性失活后脂肪变性发展早期的作用，目的3和4研究了HIF-2在野生型遗传背景中的作用，重点是与脂肪变性发展相关的HIF-2靶基因。所提出的研究不仅对我们理解HIF在脂质代谢中的基本功能很重要，更重要的是具有直接的临床相关性。我们提供了缺氧损伤和脂肪肝发展之间的直接分子联系，并建立了HIF通路在NAFLD发病机制中的新作用。